Cargando…
Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review
Background: Gut microbiome is proved to affect the activity of immunotherapy in certain tumors. However, little is known if there is universal impact on both the treatment response and adverse effects (AEs) of immune checkpoint inhibitors (ICIs) across multiple solid tumors, and whether such impact...
Autores principales: | Huang, Chengliang, Li, Meizhang, Liu, Ben, Zhu, Huanbo, Dai, Qun, Fan, Xianming, Mehta, Kathan, Huang, Chao, Neupane, Prakash, Wang, Fen, Sun, Weijing, Umar, Shahid, Zhong, Cuncong, Zhang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012896/ https://www.ncbi.nlm.nih.gov/pubmed/33816289 http://dx.doi.org/10.3389/fonc.2021.642110 |
Ejemplares similares
-
Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
por: Liu, Ben, et al.
Publicado: (2022) -
Immunotherapy in genitourinary malignancies
por: Mehta, Kathan, et al.
Publicado: (2017) -
Gut Microbiome and the Response to Immunotherapy in Cancer
por: Stancu, Andreea Lucia
Publicado: (2018) -
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
por: Chau, Justin, et al.
Publicado: (2021) -
Role of gut microbiome on immunotherapy efficacy in melanoma
por: Bibbò, Stefano, et al.
Publicado: (2021)